The Global Healthcare Consortium

Unified care,
across every border.

iWorldcare™ is a mission-locked global consortium building the sovereign-aligned infrastructure that lets patients, providers, payors, and policymakers collaborate across borders — where profit follows from value created, not value extracted.

Become a founding member Read the blueprint
Founded 2026 · USA Founding sponsor: IMEUS For-profit · Mission-locked www.iWorldcare.com
Concept Genesis
The Founding Thesis
Healthcare value at scale requires sustained reinvestment, professional execution, and aligned incentives. Donor models cannot retain talent. Extractive commercial models elevate cost rather than create value. iWorldcare is the third path — mission-locked for-profit infrastructure where profit is the mechanism of sustained value creation, not the purpose of the institution.
— iWorldcare Founding Blueprint, §2.2
§ 01 — At a glance
A consortium engineered
for value, not extraction.

Four numbers that define the structural commitments iWorldcare makes to its members and stakeholders — entrenched in the constitution, not aspirational claims.

25%
Maximum value-capture cap
30–40%
Profit reinvestment minimum
30–50%
Patronage pool to delivery members
06
Stakeholder classes governed
§ 02 — Strategic pillars
Six pillars of cross-border healthcare.

Each pillar is a distinct line of value creation with its own measurement methodology, member proposition, and roadmap. iWorldcare launches with Pillars 1 and 2; Pillars 3–6 phase in as platform maturity and member capacity allow.

Pillar 01
Cross-Border Clinical Interoperability

Patient records, clinical history, imaging, and lab results that travel with the patient across jurisdictions — under sovereignty-preserving data architecture.

Launch phase · Year 1–3
Pillar 02
Sovereign Health Intelligence

Federated analytics and AI-augmented decision support — data stays at source, insights and models flow safely between jurisdictions.

Launch phase · Year 1–3
Pillar 03
Cross-Border Care Delivery

Telemedicine, second opinions, specialist consultation, and mobile patient access — supported by credentialing recognition and payment rails.

Phase II
Pillar 04
Cross-Border Health Financing

Insurance portability, payor-to-payor settlement, claims interoperability, and sovereign-health-financing collaboration.

Phase II
Pillar 05
Cross-Border Workforce

Credentialing recognition, training collaboration, and talent mobility — letting scarce specialist capacity serve demand across jurisdictions.

Phase III
Pillar 06
Cross-Border Supply & Procurement

Group purchasing, supply chain resilience, and regulatory harmonization on pharmaceuticals and devices, at cross-border scale.

Phase III
§ 03 — The economics
Profit from value created, never from value extracted.

iWorldcare's economic model is engineered so that its income comes from savings, efficiencies, and outcomes the consortium demonstrably creates — and never from cost shifting, rent on data, or price elevation imposed on patients, providers, or payors.

How iWorldcare earns

  • Shared-savings contracts.Baseline established, savings measured, defined share captured. No savings, no fee.
  • Outcomes-based pricing.Payment tied to defined clinical, operational, or financial outcomes achieved.
  • Patronage distributions.Profit returns to delivery members in proportion to the value they generate.
  • Value-anchored subscriptions.Predictable revenue capped as a fraction of measured value delivered.
  • Cross-border transaction fees.Defined fees on flows the consortium enables that would not otherwise occur.

What iWorldcare will not charge

  • Cost elevation to patients.No fee structure that raises the price of care to the patient.
  • Provider or payor markup capture.No fees that elevate the prices providers charge patients or payors.
  • Data rent without return.Data contributors participate in the economic value derived from their data.
  • Vendor lock-in fees.Members retain the right to exit with their data, on defined terms.
  • Fees without measured value.Revenue mechanics disconnected from value creation are constitutionally prohibited.
The Founding Cohort

The first eight to twelve founders will shape the institution that follows.

iWorldcare is recruiting an anchor cohort of sovereign entities, major providers, payors, capital partners, and standards bodies — distributed across geographies and the six stakeholder classes. The cohort closes when the institution launches publicly. The first three signatures determine the next ninety-seven.

§ About · Founding premise
A new institution
for unified cross-border care.

Healthcare today is structurally national, increasingly digital, and economically extractive. Patients move across borders for care, but their records, their financing, and their continuity do not move with them.

No existing institution combines four elements at once: genuine cross-border interoperability across clinical, financial, and administrative layers; for-profit economics that sustain reinvestment without extraction; sovereign acceptability across geopolitical and regulatory boundaries; and stakeholder governance that aligns providers, payors, patients, and policymakers.

iWorldcare exists to build that institution.

What iWorldcare is

iWorldcare is an independent legal entity, founded and catalyzed by IMEUS, governed under a sponsor-led model designed to combine decisive execution with stakeholder legitimacy. It is a global consortium that brings together sovereign entities, major provider institutions, payors, capital partners, technology contributors, and standards bodies — in a single platform engineered to dissolve the structural friction that fragments healthcare across borders today.

The consortium is for-profit and mission-locked. Its profits derive from value it demonstrably creates, measured as savings, efficiencies, and outcomes. Where no value is created, no profit is taken. Where value is created, a defined and capped share accrues to the consortium, while the majority flows back to delivery members and is reinvested into expanding the platform.

What iWorldcare is not

iWorldcare is not a standards body. Not a non-profit alliance. Not a vendor consortium. Not an extension of any founding member's commercial offering. Not a captive of any sovereign, capital partner, or technology contributor. It is an institution engineered to outlast any individual founder, partner, or sponsor — including the one that catalyzed it.

The path from here

iWorldcare's founding work runs through the next eighteen months: a small founding cohort of eight to twelve anchor members, a clear constitutional design with entrenched mission lock, a credible savings-and-efficiencies economic model with capped value capture, and the discipline to launch with deliverables in hand rather than aspirations on paper.

The blueprint exists. The work begins now.

§ Founding principles
Seven principles, entrenched in the constitution.

These principles may only be amended by 75% supermajority of voting members. They define what iWorldcare is — and what it must not become.

01
Stakeholder primacy
iWorldcare serves Persons, Patients, Providers, Payors, Planners, and Policymakers — and balances their interests through structured governance, not shareholder primacy alone.
02
Sovereignty preserved
Member-jurisdiction data, regulatory authority, and policy primacy remain with the sovereign. iWorldcare operates within sovereignty, never around or above it.
03
Value before profit
Profit is taken only where measurable value has been created. Where no value is demonstrated, no profit is captured.
04
Anti-extraction
iWorldcare does not elevate the price or cost of care. It does not extract rent on data without economic return to the data's source. It does not lock members into dependencies.
05
Reinvestment commitment
A defined minimum share of distributable profit is reinvested into the platform, member capability, and underserved-market expansion.
06
Transparency & measurement
All value claims are measured against published methodologies, independently verified, and disclosed in annual integrated reporting.
07
Pluralism by design
Open to multiple technology contributors, multiple capital sources, and multiple sovereign systems. No single member captures the consortium.
§ Strategic pillars
Six pillars of cross-border healthcare value.

Each pillar is a distinct line of value creation with its own measurement methodology, member proposition, and roadmap. Pillars 1 and 2 launch first; Pillars 3–6 phase in as platform maturity and member capacity allow.

Pillar 01
Cross-Border Clinical Interoperability

Patient records, clinical history, imaging, and lab results travel with the patient across jurisdictions — under sovereignty-preserving data architecture. The foundational layer beneath every other pillar.

Launch phase · Year 1–3
Pillar 02
Sovereign Health Intelligence

Federated analytics, AI-augmented decision support, and cross-jurisdictional intelligence — engineered so that data stays at source while insights and models can be shared safely.

Launch phase · Year 1–3
Pillar 03
Cross-Border Care Delivery

Telemedicine, second opinions, specialist consultation, medical tourism, and mobile patient access — supported by credentialing recognition, regulatory interoperability, and payment rails.

Phase II
Pillar 04
Cross-Border Health Financing

Insurance portability, payor-to-payor settlement, claims interoperability, and sovereign-health-financing collaboration. The hardest layer to deliver, with the highest economic value when achieved.

Phase II
Pillar 05
Cross-Border Workforce & Capability

Credentialing recognition, training collaboration, talent mobility, and workforce platforms — letting scarce specialist capacity in one jurisdiction serve unmet demand in another.

Phase III
Pillar 06
Cross-Border Supply & Procurement

Group purchasing, supply chain resilience, regulatory harmonization on pharmaceuticals and devices, and cross-border procurement that captures scale economies for sovereign members.

Phase III
§ Governance
Sponsor-led at launch.
Stakeholder-aligned by design.

Consensus models crash consortia at formation. iWorldcare is sponsor-led, with narrow but credible reserved matters, strong information rights, and a defined path to broader governance as the institution matures.

Tier 01 · Management

Sponsor-led authority

The vast majority of decisions, executed under board oversight.

  • Product roadmap and platform architecture
  • Engineering and technology stack
  • Operating budget within envelope
  • Vendor selection and partnerships
  • Brand and external communications
  • Working group chartering
Tier 02 · Board

Board approval required

Simple majority of board, sponsor-controlled at formation.

  • Annual budget and business plan
  • Senior hires (CEO and direct reports)
  • Material contracts above thresholds
  • New product lines and partnerships
  • Distributions and reserves policy
  • Adoption of working group outputs
Tier 03 · Reserved

Supermajority of members (75%)

A deliberately narrow list — the constitutional bedrock.

  • Constitutional or charter amendments
  • Mission lock changes
  • Economic waterfall changes
  • Sale or change of control
  • Data sovereignty rules
  • Material related-party contract changes
  • Dissolution

Board composition at formation

Seat category
Count
Notes
Founding Sponsor
IMEUS
4 seats
Sponsor-controlled at formation; reduces over time per sunset schedule.
Anchor Founders
Class B
2 seats
Elected by founding partner class; rotates by stakeholder category.
Independent Directors
2 seats
Truly independent — healthcare, governance, and ethics expertise.
Independent Chair
1 seat
Founding chair from IMEUS; transitions to fully independent by Year 5.
§ Membership architecture
Five classes,
one stakeholder institution.

iWorldcare adopts a multi-class membership structure designed to accommodate diverse stakeholders while preserving governance clarity. The founding cohort target is eight to twelve Class B anchor founders, with the institution scaling to one hundred-plus members within thirty-six months of public launch.

Class
Profile
Buy-in / Dues
Rights and role
Founding Sponsor
Class A
IMEUS — founding sponsor, IP contributor, initial operating partner.
IP and capital contribution
Founder shares, sponsor-led board majority (sunsetting), reserved-matter rights, brand stewardship.
Anchor Founders
Class B
Sovereigns, major providers, payors, capital and technology partners. 8–12 at formation.
USD 1M–5M founding capital + annual dues
Equity participation, elected board seats, full voting on reserved matters, patronage participation.
Strategic Members
Class C
Major institutions across the 6P stakeholder categories.
USD 100K–500K annual dues
Non-equity participation units, Member Council representation, patronage tied to usage.
Operating Members
Class D
Hospitals, clinics, payors, integrators, smaller institutions.
USD 25K–100K annual dues (tiered)
Platform access, working group participation, patronage distributions, limited voting.
Affiliates
Class E
Academic, civil society, ecosystem partners.
USD 5K–25K or in-kind
Observer status, working group access, no voting.
Sovereign Membership Provisions

Sovereign and quasi-sovereign members are accommodated through specific structural provisions: participation via local subsidiary equity to satisfy sovereign procurement rules; reserved consultation rights on changes affecting jurisdictional carve-outs; constitutionally written pricing tiers for public health systems; and data sovereignty guarantees that member-jurisdiction data does not leave that jurisdiction even where iWorldcare operates the platform.

§ Members
The founding
cohort.

iWorldcare's founding membership is being constituted across geographies and the six stakeholder classes. The cohort closes when the institution launches publicly. Inquiries from prospective founders are received in confidence.

Status

Founding cohort recruitment in progress.

The founding membership of iWorldcare is being assembled through structured engagement with anchor sovereigns, providers, payors, capital partners, and standards bodies. Prospective founders are received in confidence; the cohort will be announced collectively at public launch.

Initiate a founder conversation

Cohort composition

The founding cohort is designed for global credibility and stakeholder balance — distributed across at least four geographies, with anchor representation in each of the six stakeholder categories.

Sovereign & Quasi-Sovereign

0 / 3 confirmed
  • Anchor sovereign — ASEAN (in dialogue)
  • Anchor sovereign — GCC (in dialogue)
  • Sovereign development capital partner (in dialogue)

Provider Institutions

0 / 3 confirmed
  • Major integrated health system (in dialogue)
  • Hospital group — ASEAN (in dialogue)
  • Academic medical center (in dialogue)

Payor Institutions

0 / 2 confirmed
  • National insurer / social health fund (in dialogue)
  • Major private payor group (in dialogue)

Capital Partners

0 / 2 confirmed
  • Development finance institution (in dialogue)
  • Impact-aligned strategic capital (in dialogue)

Standards & Academic

0 / 2 confirmed
  • Global health standards body (in dialogue)
  • Academic policy institution (in dialogue)

Technology Contributors

1 / 2 confirmed
  • IMEUS — founding sponsor & initial operating partner
  • Additional technology contributor (in dialogue)
Founding Sponsor

IMEUS catalyzes — iWorldcare endures.

IMEUS is the founding sponsor and catalyst of iWorldcare, contributing foundational intellectual property, brand stewardship, technical architecture, and initial operating capacity. IMEUS participates in iWorldcare as a member and as an arm's-length operating partner, under defined founder rights that sunset on defined milestones. iWorldcare is structurally independent from IMEUS.

§ Contact · [email protected]
Initiate a founder conversation.

Inquiries from prospective founding members, sovereign partners, capital partners, and institutional collaborators are received in confidence. Initial conversations are exploratory; substantive engagement proceeds under NDA.

Direct channels
to the consortium.

For founding partner inquiries, sovereign engagement, capital partnership conversations, or institutional collaboration requests — reach the iWorldcare founding team directly.

Enquiry email
[email protected]
WhatsApp
+60 19 901 3844
Founding sponsor
IMEUS
Registered office
Delaware
USA

Founding partner enquiry

Submitted enquiries are received by the iWorldcare founding team in confidence. Response within five business days.

By submitting, you consent to confidential review by the iWorldcare founding team. No information is shared externally.